학술논문

Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients with Recurrent Glioblastoma: BrUOG329, A Phase i Brown University Oncology Research Group Trial
Document Type
Article
Source
In: American Journal of Clinical Oncology: Cancer Clinical Trials. (American Journal of Clinical Oncology: Cancer Clinical Trials, February 2021, 44(2):49-52)
Subject
Language
English
ISSN
1537453X
02773732